Single-Arm Study of the Efficacy and Safety of Oral Rigosertib in Patients With Myelofibrosis (MF) and Anemia
Clinical trial NCT02730884 · TERMINATED
Trial details
- NCT number
- NCT02730884
- Sponsor
- M.D. Anderson Cancer Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-16
- Primary completion
- 2019-08-22
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.